Eeson Rajendra
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy.
Journal: Science advances
Published: June 12, 2026
Deciphering the phenotypic responses to 177Lu-based radioligand therapy to identify efficacious combinations.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 20, 2026
The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 06, 2026
Discovery of ART5537: A Potent and Selective Small-Molecule Probe for EXO1.
Journal: Journal of medicinal chemistry
Published: December 08, 2025
Fragment-Based Discovery and Structure-Led Optimization of MSC778, the First Potent, Selective, and Orally Bioavailable FEN1 Inhibitor.
Journal: Journal of medicinal chemistry
Published: September 17, 2025
Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapy.
Journal: Nucleic acids research
Published: June 27, 2025
Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-based Reporter Assays.
Journal: Journal of visualized experiments : JoVE
Published: July 01, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 15, 2023
Correction to "Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta".
Journal: Journal of medicinal chemistry
Published: February 23, 2023
Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta.
Journal: Journal of medicinal chemistry
Published: October 06, 2022
Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 27, 2022
Last Updated: 09/26/2026